Subscribe
Sign in
Home
Podcast
Business Acumen
QMSR Compliance
Wall of Love
Archive
About
Latest
Top
Discussions
LTR 59: FDA's pre-sub program and how it can accelerate medical device innovation
Insights from a Let's Talk Risk! conversation with Amit Guruprasad
18 hrs ago
Share this post
LTR 59: FDA's pre-sub program and how it can accelerate medical device innovation
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
32:13
Quick Tip: Treat clinical evaluation as a process, not a report
Insights from a conversation with Florian Tolkmitt
Jul 22
Share this post
Quick Tip: Treat clinical evaluation as a process, not a report
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
LTR 59: Tips for clinicians transitioning into a medical safety role in MedTech
Insights from a Let's Talk Risk! conversation with Dr. Juan Daccach
Jul 19
1
Share this post
LTR 59: Tips for clinicians transitioning into a medical safety role in MedTech
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
1
41:22
Regulating generative AI needs a new approach. Here is one idea.
Human-like AI agents are coming soon to healthcare, but risks are not fully understood and the regulatory framework is lagging behind the technology…
Jul 17
Â
•
Â
Naveen Agarwal, Ph.D.
1
Share this post
Regulating generative AI needs a new approach. Here is one idea.
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
Quick Tip: Make sure everyone has the same understanding of risk terminology
Insights from a conversation with Hugo Felix
Jul 15
Share this post
Quick Tip: Make sure everyone has the same understanding of risk terminology
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
LTR 57: It's time to focus on supply chain resiliency not just supplier management
Insights from a Let's Talk Risk! conversation with Marco Felsberger
Jul 12
3
Share this post
LTR 57: It's time to focus on supply chain resiliency not just supplier management
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
34:08
Business acumen - new LTR feature to help you achieve the success you deserve
Because technical knowhow alone is not sufficient to grow your QA/RA career in MedTech, we are launching a new section to help you build business…
Jul 10
Â
•
Â
Naveen Agarwal, Ph.D.
3
Share this post
Business acumen - new LTR feature to help you achieve the success you deserve
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
Quick Tip: A simple trick to establish a risk policy
There is no requirement to have a standalone policy for risk acceptability. There is a simple way to be both compliant and effective.
Jul 8
Share this post
Quick Tip: A simple trick to establish a risk policy
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
LTR 56: How to communicate effectively with senior management
Insights from a Let's Talk Risk! conversation with Victor Mencarelli
Jul 5
2
Share this post
LTR 56: How to communicate effectively with senior management
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
31:27
Webinar 10: Tips for medical device software risk analysis
An overview of key challenges and tips for analyzing the risks of medical device software failures.
Jul 3
Â
•
Â
Naveen Agarwal, Ph.D.
3
Share this post
Webinar 10: Tips for medical device software risk analysis
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
48:31
Quick Tip: Integrate supplier risk with product risk in your FMEAs
Insight from a conversation with Kevin Posey
Jul 1
3
Share this post
Quick Tip: Integrate supplier risk with product risk in your FMEAs
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
June 2024
LTR 55: FDA warning letter analysis, IVD risk management and career tips with Dr. Emanuel Tkach
Deep insights from a conversation with Dr. Emanuel Tkach.
Jun 28
Â
•
Â
Naveen Agarwal, Ph.D.
Share this post
LTR 55: FDA warning letter analysis, IVD risk management and career tips with Dr. Emanuel Tkach
naveenagarwalphd.substack.com
Copy link
Facebook
Email
Note
Other
56:20
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts